|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Personal history of benign neoplasm
ICD-10 (CM) Code and Descriptor
|
Z86.012 |
Personal history of benign carcinoid tumor
This code is considered unacceptable as a principal diagnosis.
|
Z86012 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 9.69%
|
20.57%
|
14.61%
|
10.43%
|
7.75%
|
5.96%
|
5.14%
|
5.14%
|
3.65%
|
3.87%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z86.012*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
30
|
30
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
26
|
27
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
24
|
24
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
17
|
254
|
|
80053
|
COMPREHEN METABOLIC PANEL |
13
|
13
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
12
|
12
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
11
|
19
|
|
71250
|
CT THORAX DX C- |
11
|
11
|
|
83497
|
ASSAY OF 5-HIAA |
10
|
10
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
9
|
1,015
|
|
G1004
|
CDSM NDSC |
8
|
12
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
8
|
8
|
|
82565
|
ASSAY OF CREATININE |
7
|
7
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
5
|
5
|
|
A9572
|
INDIUM IN-111 PENTETREOTIDE |
5
|
10
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
5
|
54
|
|
80048
|
METABOLIC PANEL TOTAL CA |
5
|
5
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
5
|
6
|
|
71260
|
CT THORAX DX C+ |
5
|
5
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
5
|
5
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z86.012 related to the following DRG Codes:
951
|
